Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $1,416,719 (100.0% shares, 0.0% debt)

Holdings (33)

MERUS N V 13.1%
Value ($000) $185,415 Shares 3,525,000 Est. Cost $29.97 Unrealized
NUVL NUVALENT INC 7.4%
Value ($000) $104,913 Shares 1,375,000 Est. Cost $67.11 Unrealized +9.0%
XENE XENON PHARMACEUTICALS INC 6.7%
Value ($000) $94,683 Shares 3,025,000 Est. Cost $30.82 Unrealized +5.9%
ELVN ENLIVEN THERAPEUTICS INC 6.6%
Value ($000) $94,138 Shares 4,692,809 Est. Cost $19.08 Unrealized -0.8%
AGIO AGIOS PHARMACEUTICALS INC 5.5%
Value ($000) $77,330 Shares 2,325,000 Est. Cost $33.00 Unrealized -8.2%
CLDX CELLDEX THERAPEUTICS INC NEW 5.0%
Value ($000) $70,208 Shares 3,450,000 Est. Cost $22.13 Unrealized -12.1%
ALKS ALKERMES PLC 4.9%
Value ($000) $70,095 Shares 2,450,000 Est. Cost $26.49 Unrealized +12.3%
VRDN VIRIDIAN THERAPEUTICS INC 4.8%
Value ($000) $68,153 Shares 4,875,000 Est. Cost $15.97 Unrealized -15.0%
PTGX PROTAGONIST THERAPEUTICS INC 4.2%
Value ($000) $59,415 Shares 1,075,000 Est. Cost $47.99 Unrealized 0.0%
CIDARA THERAPEUTICS INC 4.0%
Value ($000) $57,234 Shares 1,175,000 Est. Cost $48.71 Unrealized
SRRK SCHOLAR ROCK HLDG CORP 3.6%
Value ($000) $51,359 Shares 1,450,000 Est. Cost $35.25 Unrealized -11.0%
SLNO SOLENO THERAPEUTICS INC 3.6%
Value ($000) $51,106 Shares 610,000 Est. Cost $40.45 Unrealized +85.1%
RLAY RELAY THERAPEUTICS INC 3.3%
Value ($000) $46,191 Shares 13,350,000 Est. Cost $2.97 Unrealized 0.0%
NRIX NURIX THERAPEUTICS INC 3.2%
Value ($000) $44,975 Shares 3,948,653 Est. Cost $21.29 Unrealized -49.2%
CNTA CENTESSA PHARMACEUTICALS PLC 3.1%
Value ($000) $43,340 Shares 3,298,289 Est. Cost $15.31 Unrealized
PHVS PHARVARIS N V 2.4%
Value ($000) $33,641 Shares 1,911,433 Est. Cost $23.20 Unrealized -30.5%
KYMR KYMERA THERAPEUTICS INC 2.3%
Value ($000) $32,730 Shares 750,000 Est. Cost $34.43 Unrealized 0.0%
MIND MEDICINE MINDMED INC 2.3%
Value ($000) $32,450 Shares 5,000,000 Est. Cost $8.32 Unrealized
SYRE SPYRE THERAPEUTICS INC 2.1%
Value ($000) $29,762 Shares 1,988,084 Est. Cost $14.79 Unrealized +0.1%
TYRA TYRA BIOSCIENCES INC 2.1%
Value ($000) $29,667 Shares 3,100,000 Est. Cost $10.56 Unrealized -10.0%
VERA VERA THERAPEUTICS INC 1.3%
Value ($000) $18,848 Shares 800,000 Est. Cost $13.95 Unrealized +61.2%
CTMX CYTOMX THERAPEUTICS INC 1.2%
Value ($000) $17,462 Shares 7,692,300 Est. Cost $1.61 Unrealized 0.0%
COGT COGENT BIOSCIENCES INC 1.2%
Value ($000) $16,594 Shares 2,311,164 Est. Cost $8.14 Unrealized -31.9%
ORKA ORUKA THERAPEUTICS INC 1.1%
Value ($000) $15,915 Shares 1,419,714 Est. Cost $34.43 Unrealized -69.7%
DRUG BRIGHT MINDS BIOSCIENCES INC 0.9%
Value ($000) $13,055 Shares 500,000 Est. Cost $35.19 Unrealized -14.8%
APGE APOGEE THERAPEUTICS INC 0.9%
Value ($000) $12,595 Shares 290,000 Est. Cost $25.01 Unrealized +52.1%
IKT INHIBIKASE THERAPEUTICS INC 0.7%
Value ($000) $10,525 Shares 5,397,488 Est. Cost $2.49 Unrealized -21.5%
PCSC PERCEPTIVE CAP SOLUTIONS COR 0.6%
Value ($000) $7,965 Shares 750,000 Est. Cost $10.07 Unrealized +3.8%
TNGX TANGO THERAPEUTICS INC 0.5%
Value ($000) $7,680 Shares 1,500,000 Est. Cost $2.47 Unrealized 0.0%
CBIO CRESCENT BIOPHARMA INC. 0.5%
Value ($000) $7,322 Shares 453,686 Est. Cost $21.15 Unrealized 0.0%
NGNE NEUROGENE INC 0.5%
Value ($000) $6,397 Shares 427,866 Est. Cost $33.71 Unrealized -53.4%
VTGN VISTAGEN THERAPEUTICS INC 0.2%
Value ($000) $3,150 Shares 1,575,000 Est. Cost $4.44 Unrealized -48.8%
AVTX AVALO THERAPEUTICS INC 0.2%
Value ($000) $2,410 Shares 483,000 Est. Cost $10.53 Unrealized -55.6%